Skip to main content
Log in

Adalimumab/ciclosporin

Lack of efficacy: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Reference

  • Abdelmaksoud A, et al. Response of chronic refractory psoriasis vulgaris with urticaria to combined secukinumab and omalizumab: A case report and review of the literature. Journal of Cosmetic Dermatology 22: 1416-1418, No. 4, Apr 2023. Available from: URL: http://dx.doi.org/10.1111/jocd.15551

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adalimumab/ciclosporin. Reactions Weekly 1969, 22 (2023). https://doi.org/10.1007/s40278-023-44488-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-44488-7

Navigation